DB05950ExperimentalSmall molecule
Contulakin-G is a broad spectrum non-opioid analgesic. It is the synthetic form of a natural peptide extracted from the venom of the Conus Geographus sea snail.
- Mechanism
- Curator reviewed
CGX-1160 operates by activating the G-protein-coupled neurotensin NTR1 receptor (Prialt(R) inhibits the unrelated ion channel, n-type calcium channel), is a linear and smaller peptide, and has a significantly superior safety profile and therapeutic index than Prialt(R).
- Primary indication
- Investigated for use/treatment in pain (acute or chronic).Curator reviewed
- Code names
- CGX-1160
Resolves to
Compound
Targets
What you can answer from here — as of March 06, 2025
2Protein targetsEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with Contulakin-G, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account